Mucosal Immunity Against Neisseria Gonorrhoeae After 4CMenB Vaccination

NCT04722003 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

52

Enrollment

NIH

Sponsor class

Conditions

Gonorrhoea

Interventions

BIOLOGICAL: Meningococcal Group B Vaccine
OTHER: Placebo

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)